Market Place
Sourcing Support
Pfizer-backed CellCentric secures $120M for ph. 3 myeloma trial
20 May 2025 //
FIERCE BIOTECH
Novavax shares jump after FDA approval of its COVID-19 vaccine
20 May 2025 //
REUTERS
Atsena gene therapy hits safety goals, closes retinal splits
20 May 2025 //
FIERCE BIOTECH
Boehringer`s phase 3 lung data get muted response from analysts
20 May 2025 //
FIERCE BIOTECH
FDA approves Novavax COVID vaccine with new conditions
20 May 2025 //
REUTERS
AB Science gets Chinese patent for masitinib in Covid-19
19 May 2025 //
GLOBENEWSWIRE
LIfT BioSciences Highlights Alpha Neutrophils at ISCT
19 May 2025 //
GLOBENEWSWIRE
Regeneron plans to buy 23andMe for $256M
19 May 2025 //
ENDPTS
Innovent`s 2024 ESG Report Highlights Sustainable Commitment
18 May 2025 //
PR NEWSWIRE
Tessera Therapeutics Presents New Preclinical Data at ASGCT 28th
17 May 2025 //
GLOBENEWSWIRE
Fractyl Health Reveals Rejuva® Smart GLP-1™ Pancreatic Gene Therapy
17 May 2025 //
GLOBENEWSWIRE
Brain Cancer Canada Funds $68,000 Trial for DIPG Vaccine
17 May 2025 //
GLOBENEWSWIRE
Tectonic Therapeutic Presents Complete Results of TX45 Phase 1b
17 May 2025 //
GLOBENEWSWIRE
AMVUTTRA® (vutrisiran) Reduces Mortality and Cardiovascular Event
17 May 2025 //
BUSINESSWIRE
Be Biopharma Unveils BE-102 Data for Hypophosphatasia
17 May 2025 //
BUSINESSWIRE
Lilly strengthens RNA pipeline with $1.3B hearing loss pact
17 May 2025 //
FIERCE BIOTECH
BioMarin Inks $270M Inozyme buyout, phase 3 prospect
17 May 2025 //
PRESS RELEASE
Incyte Secures Anal Cancer Nods Years After FDA Rejection
17 May 2025 //
FIERCE PHARMA
AGC Biologics Partners with Quell for Cell Therapy Development
17 May 2025 //
PRESS RELEASE
Amgen owes Regeneron $407M after defeat in PCSK9 antitrust suit
17 May 2025 //
FIERCE PHARMA
Neurocrine Biosciences Presents Data on Tardive Dyskinesia
16 May 2025 //
PR NEWSWIRE
Neurocrine Biosciences to Present One-Year Data at PES 2025
16 May 2025 //
PR NEWSWIRE
Lamassu Biotech partners Ohio State Univ. for new therapy study
16 May 2025 //
PR NEWSWIRE
SNS812 siRNA COVID Drug Chosen for ATS 2025 Talk
16 May 2025 //
PR NEWSWIRE
Vivex Chair Nominated for EY Entrepreneur of the Year
16 May 2025 //
GLOBENEWSWIRE
FibroBiologics Presents at Dermatology Meeting
16 May 2025 //
GLOBENEWSWIRE
4DMT Announces New Employment Inducement Grants
16 May 2025 //
GLOBENEWSWIRE
Iovance Bio Reports Inducement Grants under Nasdaq LR 5635(c)(4)
16 May 2025 //
GLOBENEWSWIRE
Bristol Myers gets EU approval for Opdivo regimen in lung Cancer
16 May 2025 //
BUSINESSWIRE
Marea Therapeutics Publishes Positive Phase 2a MAR001 Data
16 May 2025 //
BUSINESSWIRE
Sarepta Shows Strong EMBARK Data in Gene Therapy Study
16 May 2025 //
BUSINESSWIRE
Sarepta Therapeutics Shares New Endeavor Results in 2-Year-Olds
16 May 2025 //
BUSINESSWIRE
Coya Therapeutics at H.C. Wainwright BioConnect Conference
16 May 2025 //
BUSINESSWIRE
Acuitas Therapeutics Collaborates with Children`s Hospital
16 May 2025 //
BUSINESSWIRE
JCR Pharmaceuticals Presents Promising CNS Uptake Data at ASGCT
16 May 2025 //
BUSINESSWIRE
BioRewards & Alpha-1 Launch $100M Plasma Expansion Plan
16 May 2025 //
BUSINESSWIRE
Liberate Bio Updates on Raptor LNP Platform and CAR-M Programs
16 May 2025 //
BUSINESSWIRE
NanoViricides Updates on NV-387, Targets MPox, Measles, Flu
16 May 2025 //
ACCESSWIRE
US seeks Information from Pfizer over alleged COVID vaccine delay
16 May 2025 //
REUTERS
Immutep’s efti with PD-L1 achieves high response in lung cancer
16 May 2025 //
GLOBENEWSWIRE
RFK Jr. Firm on HHS Cuts, Wobbles on Measles Vaccine
16 May 2025 //
BIOSPACE
Faron Accepts Bexmarilimab Data for EHA 2025 Congress
15 May 2025 //
ACCESSWIRE
Precision BioSciences Reports Q1 2025 Results and Business Update
15 May 2025 //
BUSINESSWIRE
TriSalus Life Sciences Reports Q1 2025 Results and Guidance
15 May 2025 //
BUSINESSWIRE
NewSpring Capital and Kineticos Lead $22M Investment in Kincell B
15 May 2025 //
BUSINESSWIRE
Janux Therapeutics names Janeen Doyle Chief Corporate Officer
15 May 2025 //
BUSINESSWIRE
bioAffinity Technologies Reports First Quarter 2025 Results
15 May 2025 //
BUSINESSWIRE
Atara Biotherapeutics Q1 Financial Results and Progress
15 May 2025 //
BUSINESSWIRE
Tivic Reports Q1 2025 Financial Results and Business Updates
15 May 2025 //
BUSINESSWIRE
Aura Biosciences Reports Q1 2025 Financial Results and Highlights
15 May 2025 //
GLOBENEWSWIRE
Pyxis Oncology Reports Q1 2025 Financials and Business Update
15 May 2025 //
GLOBENEWSWIRE
I-Mab Reports Q1 2025 Financial Results and Business Update
15 May 2025 //
GLOBENEWSWIRE
Abeona Therapeutics Reports Q1 2025 Financial Results and Updates
15 May 2025 //
GLOBENEWSWIRE
MiNK Therapeutics Reports Q1 2025 Results and Progress
15 May 2025 //
GLOBENEWSWIRE
Chemomab Therapeutics Announces Q1 2025 Results & Update
15 May 2025 //
GLOBENEWSWIRE
Opus Genetics Reports Q1 2025 Results and Corporate Update
15 May 2025 //
GLOBENEWSWIRE
Taysha Gene Therapies Q1 2025 Financial Results & Update
15 May 2025 //
GLOBENEWSWIRE
Akari Therapeutics Reports Q1 2025 Financial Results
15 May 2025 //
GLOBENEWSWIRE
GRI Bio Reports Q1 2025 Results, GRI-0621 IPF Trial on Track
15 May 2025 //
GLOBENEWSWIRE
GT Biopharma Appoints New Member to its Board of Directors
15 May 2025 //
GLOBENEWSWIRE
